Immunicom Competitors and Similar CompaniesClear all

IO Biotech's competitors and similar companies include MaxCyte and TScan Therapeutics.
IO Biotech
IO Biotech
IO Biotech is a clinical-stage biotech company developing immune-modulating cancer therapies.
MaxCyte
MaxCyte
MaxCyte (formerly known as Theramed) is a cell engineering company focused on providing platform technologies for cell-based research as well as cell therapeutic discovery, development, and commercialization.
TScan Therapeutics
TScan Therapeutics
TScan Therapeutics is a biotechnology company that develops cancer-targeting therapies.
Founding Date
Founding Date
2014
Founding Date
1998
Founding Date
2018
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
New York, US HQ
København, DK
Usk, GB
Rockville, US
Locations
Gaithersburg, US HQ
Alderley Edge, GB
Locations
Waltham, US HQ
Employees
Employees
19
Employees
65
Employees
7316% increase
Valuation ($)
Valuation ($)
85.3 m
Valuation ($)
387.9 m
Valuation ($)
251.6 m

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$33m (FY, 2025)
Revenue (est.)
$10.3m (FY, 2025)
Net income
Net income
($95.5m) (FY, 2024)
Net income
($44.6m) (FY, 2025)
Net income
($129.8m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 165.9m
Total funding raised
$ 31.3m
Total funding raised
$ 137.5m
For sources of this data, please see the company profile

View Company Profiles

MaxCyte
HQ
Gaithersburg, US
Employees
65

MaxCyte (formerly known as Theramed) is a cell engineering company focused on providing platform technologies for cell-based research as well as cell therapeutic discovery, development, and commercialization.

View company
TScan Therapeutics
HQ
Waltham, US
Employees
73↑ 16% increase

TScan Therapeutics is a biotechnology company that develops cancer-targeting therapies.

View company